360 related articles for article (PubMed ID: 30803759)
1. Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures.
Tsutsumi R; Hori Y; Seki T; Kurauchi Y; Sato M; Oshima M; Hisatsune A; Katsuki H
Biochem Biophys Res Commun; 2019 Apr; 511(2):427-433. PubMed ID: 30803759
[TBL] [Abstract][Full Text] [Related]
2. A natural compound macelignan protects midbrain dopaminergic neurons from inflammatory degeneration via microglial arginase-1 expression.
Kiyofuji K; Kurauchi Y; Hisatsune A; Seki T; Mishima S; Katsuki H
Eur J Pharmacol; 2015 Aug; 760():129-35. PubMed ID: 25917324
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
4. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
5. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-cyclic GMP signaling pathway limits inflammatory degeneration of midbrain dopaminergic neurons: cell type-specific regulation of heme oxygenase-1 expression.
Kurauchi Y; Hisatsune A; Isohama Y; Katsuki H
Neuroscience; 2009 Jan; 158(2):856-66. PubMed ID: 18996444
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: role of inducible nitric oxide synthase and protection by indomethacin.
Shibata H; Katsuki H; Nishiwaki M; Kume T; Kaneko S; Akaike A
J Neurochem; 2003 Sep; 86(5):1201-12. PubMed ID: 12911628
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
9. c-Jun N-terminal kinase inhibition and alpha-tocopherol protect midbrain dopaminergic neurons from interferon-gamma/lipopolysaccharide-induced injury without affecting nitric oxide production.
Shibata H; Katsuki H; Okawara M; Kume T; Akaike A
J Neurosci Res; 2006 Jan; 83(1):102-9. PubMed ID: 16307444
[TBL] [Abstract][Full Text] [Related]
10. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration.
Wang X; Chen S; Ma G; Ye M; Lu G
Mech Ageing Dev; 2005 Dec; 126(12):1241-54. PubMed ID: 16112714
[TBL] [Abstract][Full Text] [Related]
11. Dual role of histamine on microglia-induced neurodegeneration.
Barata-Antunes S; Cristóvão AC; Pires J; Rocha SM; Bernardino L
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):764-769. PubMed ID: 28057587
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture.
Katsuki H; Okawara M; Shibata H; Kume T; Akaike A
J Neurochem; 2006 Jun; 97(5):1232-42. PubMed ID: 16638023
[TBL] [Abstract][Full Text] [Related]
13. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
Kostuk EW; Cai J; Iacovitti L
J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
[TBL] [Abstract][Full Text] [Related]
14. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.
Mount MP; Lira A; Grimes D; Smith PD; Faucher S; Slack R; Anisman H; Hayley S; Park DS
J Neurosci; 2007 Mar; 27(12):3328-37. PubMed ID: 17376993
[TBL] [Abstract][Full Text] [Related]
15. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
Tu D; Gao Y; Yang R; Guan T; Hong JS; Gao HM
J Neuroinflammation; 2019 Dec; 16(1):255. PubMed ID: 31805953
[TBL] [Abstract][Full Text] [Related]
16. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
Front Immunol; 2018; 9():2527. PubMed ID: 30455692
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide preconditioning induces protection against lipopolysaccharide-induced neurotoxicity in organotypic midbrain slice culture.
Ding Y; Li L
Neurosci Bull; 2008 Aug; 24(4):209-18. PubMed ID: 18668149
[TBL] [Abstract][Full Text] [Related]
18. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Tian YY; An LJ; Jiang L; Duan YL; Chen J; Jiang B
Life Sci; 2006 Dec; 80(3):193-9. PubMed ID: 17049947
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
Lee DY; Oh YJ; Jin BK
Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
[TBL] [Abstract][Full Text] [Related]
20. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
